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ABSTRACT 
Chronic diseases are the most common, costly, and preventable health problems in the 
United States. Pharmacist-prescriber collaboration has been shown to enhance patient care and 
improve patient outcomes, especially regarding chronic disease. The purpose of this study is to 
assess pharmacists’ acceptability and perceived usefulness of a Prescription Dispensing Data 
(PDD) infographic as a tool to facilitate community pharmacist-prescriber collaboration. A PDD 
infographic highlights aggregate patient care data for mutual patients of a pharmacist-prescriber 
dyad.  
Semi-structured interviews were conducted with community pharmacists across the state 
of Pennsylvania. A convenience sample of independent community pharmacists were recruited at 
a state pharmacy association annual conference to participate in the study. Study participants that 
were members of the Pennsylvania Pharmacists Care Network were targeted for recruitment. A 
10- to 20-minute face-to-face interview was conducted with each pharmacist to determine how 
they could use the PDD infographic to initiate collaborative discussions with prescribers. The 
Technology Acceptance Model (TAM) guided interview questions, data collection, and analysis. 
Interviews were audio-recorded and transcribed verbatim. Two independent reviewers coded the 
transcripts and came to consensus. Relevant codes were grouped into major categories to identify 
prevalent themes. Members of the research team met to discuss and agree upon themes. 
David Finegold, MD 
 
ASSESSING PHARMACISTS’ ACCEPTANCE OF PRESCRIPTION DISPENSING 
DATA INFOGRAPHIC TO INITIATE PHARMACIST-PRESCRIBER 
COLLABORATION AND IMPROVE PATIENT OUTCOMES 
 
Hannah M. Renner, MPH 
University of Pittsburgh,  2018
 
v 
Ten pharmacists who practice at eight independent community pharmacies in 
Pennsylvania completed the interview. Six themes pertaining to pharmacists’ acceptability of the 
PDD infographic to facilitate pharmacist-prescriber collaboration emerged. 1) PDD infographic 
is an innovative approach for pharmacist-prescriber collaboration 2) PDD infographic is visually 
appealing and easy to understand 3) Use of actual patient data may increase community 
pharmacists’ confidence in initiating collaboration with prescribers 4) Prescription dispensing 
data to create the infographic needs to be easily generated for usability 5) Discussions about 
quality measures are important to facilitate pharmacist-prescriber collaboration regarding patient 
care services 6) Using the PDD infographic for pharmacist-prescriber collaboration may improve 
patient care and health outcomes.  
Public Health Significance: The PDD infographic is an innovative approach to 
initiate pharmacist-prescriber collaborative conversations. Implementing the PDD infographic 
as part of clinical practice may foster collaboration, team-based care, and improved patient 
outcomes. 
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1.0  INTRODUCTION 
Chronic diseases are the most common, costly, and preventable health problems in the 
United States.[1] Half of the adult population in the United States has one or more chronic disease 
and approximately one in four adults have two or more chronic diseases.[2, 3] Chronic disease 
costs the U.S. approximately $1.7 trillion annually, or about sixty cents out of every healthcare 
dollar.[2] About 80% of all medical treatments involve use of medications and people with 
chronic conditions account for 91% of all prescriptions filled in the United States.[2, 4] Therefore, 
improving medication use is crucial to managing chronic disease. Pharmacists’ education and 
training equips them with the necessary skills to deliver preventative care and wellness services, 
including comprehensive medication management services, to patients with chronic disease.[2] 
Pharmacists’ unmatched accessibility (93% of Americans live within 5 miles of a community 
pharmacy[5]) makes them an ideal provider of health care to people living in the community with 
chronic disease. Patients visit their community pharmacy an average 35 times per year[6] 
compared with visiting their primary care provider 2-3 times per year.[7] 
The Center for Disease Control and Prevention, American Public Health Association, and 
National Governors Association call for the increased role of pharmacists in the provision of 
direct patient care as members of integrated health care provider teams.[2, 8, 9] 
Collaborative Practice Agreements (CPAs) are one solution to developing such team-
based relationships, but the national uptake of CPAs has been limited. A significant challenge to 
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forming CPAs is initiating the collaborative working relationship between the pharmacist and the 
prescriber. As McDonough and Doucette state in their Staged Approach to Developing the 
Pharmacist-Physician Collaborative Working Relationship, a CPA represents a late stage in 
practitioners’ working relationship.[10, 11] Literature provides little guidance on how pharmacists 
can initiate and develop collaborative working relationships with prescribers. The 2017 
LINKAGE framework developed by the CDC focusing on the creation of community-clinical 
linkages between community pharmacists and prescribers calls for pharmacists to identify the 
unmet health needs of the community they serve and host a collaborative meeting with 
prescribers to share information and learn of each other’s priorities. Yet, the framework does not 
provide processes on how to approach the initiation of this meeting. The study described in this 
essay seeks to fill this gap by providing a systematic approach for pharmacists to initiate the 
collaborative process. 
Pharmacists frequently have contact with prescribers in their geographic area within the 
traditional prescription dispensing process, but often do not have a systematic way of identifying 
prescribers with whom to collaborate. Pharmacists currently do not have a data-driven way to 
initiate conversations centered around relationship-building and collaboration.[12] Building 
relationships with prescribers and capitalizing on existing relationships are key factors in 
pharmacist-prescriber collaboration.[11] Several studies emphasize that face-to-face meetings 
between pharmacists and prescribers are integral in establishing trust and building 
collaboration.[3, 11, 12] Relationships with prescribers are usually built socially first or out of 
familiarity.[11, 12] Role specification, trustworthiness, and relationship initiation are significant 
predictors of collaboration between pharmacists and prescribers. Zillich et al. developed a 
validated tool used to measure pharmacist-prescriber collaboration. Two important elements of 
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the tool include whether or not the pharmacist: 1) Spent time trying to learn how they can help 
the prescriber provide better care, and 2) Showed an interest in helping the prescriber improve 
his or her practice.[13-16] Currently there is no literature detailing how the pharmacist can 
undertake these two objectives. This study assesses the acceptability of using data readily 
available to community pharmacists to drive and inform conversations with prescribers about 
collaboration. 
Pharmacy dispensing data has not been previously utilized to initiate collaborative 
conversations with prescribers. Dispensing data is readily available to pharmacists and rich in 
information about the population that the pharmacy serves, such as prevalence of chronic 
conditions, patient characteristics including demographic information and medication-related 
problems and patterns (adherence, gaps in care, polypharmacy). In addition, there is information 
about the prescribers whose patients utilize the pharmacy such as: volume of prescribers’ 
patients who utilize a specific pharmacy, commonly prescribed medications specific to 
prescriber, and disease prevalence within the patient population of a specific prescriber.  
A concise way to easily convey this large amount of data is by using an infographic. An 
infographic is a visual representation of data that allows the viewer to quickly assess trends and 
comparisons between values while enabling the viewer to think critically about a particular data 
set in terms of broader patterns and implications.[17] Infographics have been used as a way to 
communicate information to the public and patients.[18-20] To a lesser extent, infographics have 
been utilized and studied as a means to communicate information to healthcare professionals.[21, 
22] Simple infographics may enhance comprehensibility of study results for clinicians.[23] While 
commonly used in the public health space[24], infographics have not been widely studied in 
collaborative efforts between pharmacists and prescribers. 
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To inform this study, a pilot project by Carroll and colleagues assessed prescribers’ 
feedback on a Prescription Dispensing Data (PDD) Infographic to be used to facilitate 
pharmacist-prescriber face-to-face meetings.[25] Each PDD infographic used in the project 
contained data on mutual patients of a top prescriber and one independent community pharmacy. 
An example of a PDD infographic is depicted in Figure 1. Carroll and colleagues found that 
prescribers perceived the PDD infographic to be useful when its contents were discussed with the 
pharmacists in a face-to-face meeting.[25] The in-person discussion was found to be particularly 
valuable due to the fact that the infographic and its presentation looked and felt different than 
receiving a traditional quality measure report in the mail, such as from a Managed Care 
Organization. Prescribers preferred the easy-to-read format of the PDD infographic and desired 
data on patient therapeutic gaps in care. The result of the pilot project was a finalized PDD 
infographic template that was used in this study. The finalized PDD infographic template 
highlights ways in which the community pharmacist can meaningfully collaborate to support 
patient care (Figure 1). 
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Figure 1. Prescription Dispensing Data (PDD) Infographic 
There is limited research of evidence-based and systematic approaches for pharmacists to 
initiate collaboration with prescribers. The PDD infographic presents data on mutual patients in a 
visually appealing format to stimulate pharmacist-prescriber collaboration. A PDD infographic 
highlights aggregate patient care data for mutual patients of a pharmacist-prescriber dyad. 
Specifically, the PDD infographic includes patient disease states, medication adherence rates, 
and polypharmacy rates inferred from prescription fill data, as well as pharmacist contact 
information, and opportunities for pharmacist-provided care. The PDD infographic template 
highlights quality measures that community pharmacists can meaningfully impact by providing 
existing patient care services. 
The next step was to assess pharmacists’ acceptability and perceived usefulness of the 
PDD infographic, which was the goal of this study.  
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1.1 OBJECTIVE 
The purpose of this study is to assess pharmacists’ acceptability and perceived usefulness 
of a Prescription Dispensing Data (PDD) Infographic as a tool to facilitate community 
pharmacist-prescriber collaboration.  
1.2 METHODS 
1.2.1 Qualitative Research Design 
The study utilized semi-structured key informant interviews. The Technology Acceptance 
Model (TAM) guided interview questions, data collection, and analysis (depicted in Figure 2). 
 
Figure 2. Technology Acceptance Model (TAM) 
 The semi-structured interview guide was designed to elicit constructs of the TAM, which 
included perceived ease of use, attitude toward using, usefulness, and behavioral intention to use 
the PDD infographic. A convenience sample of independent community pharmacists were 
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recruited at a state pharmacy association annual conference to participate in the study. Study 
participants that were members of the Pennsylvania Pharmacists Care Network were targeted for 
recruitment. A 10- to 20-minute face-to-face interview was conducted with each pharmacist to 
determine how they could use the PDD infographic to initiate collaborative discussions with 
prescribers. 
1.2.2 Data Collection and Analysis  
Interviews were audio-recorded and transcribed verbatim. All identifying information 
was removed during the transcription process. Interviews were analyzed using a generic 
qualitative approach.[26] A preliminary codebook was developed by the principal investigator 
after reviewing all the transcripts. Two reviewers independently coded the transcripts using 
NVivo10® software and met to discuss line-by-line coding decisions. Codes were assigned to 
phrases and sentences that carried meaning. The codebook was updated throughout the 
consensus process, as agreed upon by the two reviewers. Any coding discrepancies were 
resolved through discussion. Relevant codes were grouped into major categories to identify 
prevalent themes. Members of the research team met to discuss and agree upon themes.  
The study was approved as exempt by the University of Pittsburgh Institutional Review 
Board (IRB). 
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1.3 RESULTS 
Ten pharmacists who practice at eight independent community pharmacies in 
Pennsylvania were interviewed. Demographics and characteristics of participating pharmacists 
and their practice settings are summarized in Table 1 and Table 2, respectively.  
Table 1. Demographics of Pharmacist Participants 
Participant Characteristics No. (%), 
n=10 
Sex  
  Female 4 (40%) 
  Male 6 (60%) 
Age  
  <30 years 4 (40%) 
  30-49 years 6 (60%) 
Race  
  White, non-Hispanic 10 (100%) 
Years of Pharmacy Work Experience  
  0-10 years 6 (60%) 
  11-20 years 2 (20%) 
  21-30 years 2 (20%) 
Conducted any kind of prior meeting with 
a prescriber 
7 (70%) 
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Table 2. Characteristics of Participants' Pharmacy Practice Settings 
Pharmacy Characteristics No. (%), n 
= 8 
Average daily prescription volume  
  Less than 250 3 (37.5%) 
  250-499 4 (50%) 
  500-749 0 (0%) 
  750-999 1 (12.5%) 
Average number of technicians staffing daily  
  1-2 2 (25%) 
  3-4 4 (50%) 
  5-6 1 (12.5%) 
  >6 1 (12.5%) 
Average number of pharmacists staffing daily  
  1 3 (37.5%) 
  1-2 4 (50%) 
  >2 1 (12.5%) 
 
Six themes pertaining to pharmacists’ acceptability of the PDD infographic to facilitate 
pharmacist-prescriber collaboration emerged. The first two themes were related to the concept 
and look of the infographic: 1) PDD infographic is an innovative approach for pharmacist-
prescriber collaboration and 2) PDD infographic is visually appealing and easy to understand. 
Themes 3 and 4 dealt with the use of prescription dispensing data: 3) Use of actual patient data 
may increase community pharmacists’ confidence in initiating collaboration with prescribers and 
4) Prescription dispensing data to create the PDD infographic needs to be easily generated for 
usability. The last two themes regarded quality patient care: 5) Discussions about quality 
measures are important to facilitate pharmacist-prescriber collaboration regarding patient care 
services and 6) Using the PDD infographic for pharmacist-prescriber collaboration may improve 
patient care and health outcomes. Pharmacists reported that the PDD infographic is a valuable 
“conversation starter” that is relevant to both the pharmacist and the prescriber. Pharmacists 
expressed interest in using this new approach to initiate collaboration with prescribers. 
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1.3.1 Theme 1: PDD infographic is an innovative approach for pharmacist-prescriber 
collaboration. 
Pharmacists stated that they had never previously used prescription dispensing data in an 
infographic format to initiate collaboration with prescribers. One pharmacist reported previously 
using data to facilitate a face-to-face conversation with a prescriber; however, it was stated the 
data was hard to discern as it was in the format of a “busy, number-heavy report”. Pharmacists 
found the approach of using an infographic to be a unique and desirable way to approach 
collaborative conversations.  
“I’ve never created anything like this or really that similar. Usually it’s a little 
more drawn out, something for them to read later, [like] some brochures or 
newsletter type stuff. I could see [the infographic] being used way differently than 
anything I’ve used before…You might talk and leave it, or you might send it 
ahead but [this is] good to use it in the conversation.” –Pharmacist 9 
 
“I want to help patients and I know my pharmacies [are] already doing 
adherence and phone calls and we’re doing this stuff. I just don’t have a good 
way to communicate that to the prescriber other than just walking in and saying 
like “hey we do all this great stuff. And if we’re doing all this great stuff in my 
pharmacy for compliance. But if I can show the prescriber I have your patients, 
this many patients, this many of your patients are using my pharmacy. Here’s 
what we’re doing for these patients. I think that’s how I would have the 
conversation.” –Pharmacist 10 
 
“I find it interesting. I think that it’s very helpful. I could certainly see myself 
using this.” –Pharmacist 6 
 
The infographic was described to be a useful “conversation starter” that would help break 
down barriers in approaching prescribers because presenting the infographic would not request 
anything from the prescriber, but rather simply be a way to present information to the prescriber. 
 
“I think that often times providers feel as though we are asking them to kind of 
like fix everything, do everything. I feel like this is a way to look more 
collaboration and so basically like I’m presenting this information but here’s 
what I can do together to support this initiative. Because I don’t think that a lot of 
primary care providers are fully aware of all the things that we can be doing to 
help out as well.” –Pharmacist 3 
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1.3.2 Theme 2: PDD infographic is visually appealing and easy to understand. 
Pharmacists found the infographic to be visually appealing and reported the clear layout 
allowed them to discern a large amount of data in a short amount of time.  
“It looks really clear to me. I love the way that it’s laid out. I think that it makes it 
really simple and easy to understand, and it gives me just a quick snapshot. I 
think the use of the graphics and the charts, I like it. I like the colors. Overall, I 
love the look and what it tells me in a quick snapshot.” –Pharmacist 4 
 
“Infographics are important because they provide you with the high-level quick 
information.” –Pharmacist 3 
 
 “It’s very catchy and draws you in, something that would certainly be memorable 
I would think.” –Pharmacist 2 
1.3.3 Theme 3: Use of actual patient data may increase community pharmacists’ 
confidence in initiating collaboration with prescribers. 
Pharmacists reported that being equipped with data would increase their confidence and 
feelings of validity when approaching and discussing mutual patients with a prescriber. They felt 
that the preparation process of gathering and organizing the data would not only boost their own 
confidence, but that their preparation work would also convey their level of commitment to the 
prescriber. 
 
“Personally, it’d be a confidence thing. Where I just have this extra piece of info 
or something to divert attention to and just facilitate the conversation. You get off 
on a tangent talking about this or that and nothing business-related and then you 
come back and at least you know where to refocus. So to me it would just keep me 
on point. I would just feel more confident.” –Pharmacist 9 
 
“I think it just adds a layer of validity, and I think it kind of boosts 
credibility…when you’re prepared people notice, and if you want convince 
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somebody that you’re reliable and you’re invested and you’re committed, 
showing them that you’ve done your homework I think it goes a long a way…I 
think it’s an asset. You’re not just talking in theory; you’re looking at the 
numbers.” –Pharmacist 6 
 
“I think it’s good that’s there’s a lot of data that’s specific to the prescriber here 
so it shows that [you] prepared for your meeting [with] this prescriber and that 
you have something new to share with them that I think they’d be interested in. … 
I think it looks great that we’ve done our homework whenever we go to them to 
show them this. –Pharmacist 2    
 
 
It was also acknowledged that other stakeholders in the healthcare field, such as 
insurance payers have access to and utilize data all the time. It was stated that it makes sense that 
community pharmacists do the same. 
“I think this is an excellent start because especially for community pharmacies 
who don’t know how to approach a physician or have never done it. And realizing 
what data they actually have, cause you know, reality is our payers have that data 
and they use it all the time for other aspects and I think it’s very good.”  
–Pharmacist 1 
 
1.3.4 Theme 4: Prescription dispensing data to create the PDD infographic needs to be 
easily generated for usability.  
Pharmacists expressed concerns about their capability and the time required to pull the 
needed data from community pharmacy prescription dispensing systems. 
“It’s a little labor intensive cause you gotta run the reports and look at that, but I 
think that [the data is] eye-opening to physicians.” –Pharmacist 1 
 
“Well I would if I had a nicer dispensing system I would be totally fine with 
having a template and developing my own [PDD infographic]. But since my 
dispensing system is pretty archaic, I would prefer the convenience of something 
else helping me with that information.” –Pharmacist 3 
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It was recognized that different community pharmacies use different dispensing system 
softwares and there is a need for capability to pull the needed data reports across all systems for 
widespread usability. 
 
“For me it’s feeling confident that I could put this [PDD infographic] together. 
[If] there’s a template I could plug into, that it’s very clear. That even across 
dispensing systems, here’s the kind of idea or report that you could run to create 
this information like this step-by-step of how we would put this together. To me is 
the biggest barrier for using this.” –Pharmacist 4 
1.3.5 Theme 5: Discussions about quality measures are important to facilitate 
pharmacist-prescriber collaboration regarding patient care services.  
Pharmacists stated that including quality measures relevant to the prescriber on the 
infographic is key. Discussions facilitated by the infographic must center around the prescriber’s 
priorities when it comes to quality performance.  
“As long were presenting information to them that’s relevant to them with respect 
to their Alternative Payment Models, or what they’re being held accountable for 
as a prescriber.” –Pharmacist 6 
 
“[I] want to know what [prescribers] value too. I know sometimes they can pick 
their own quality measures that they’re tracking with MIPS (Merit-based 
Incentive Payment System), so if they’ve selected a quality measure that’s on here 
then definitely I’d want to leverage that. Or if they’ve expressed that they’re 
having difficulty with a measure say they say ‘I know I’m not doing so well on 
statin adherence do you have any ideas on how I could contribute?’. So having 
that that story prepared of how you could help them with areas they’re looking to 
improve.” –Pharmacist 2 
 
Pharmacists reported that the pharmacist user of the PDD infographic needs to be 
educated on and capable of discussing quality measures and how pharmacies affect quality 
measures that rate prescribers. 
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“Whoever’s going to use this [infographic] tool…how educated are they on how 
physicians get paid?...I think for this to work, whoever’s presenting this to the 
physician, they need to have an understanding [of] how do physicians get paid to 
feel comfortable to do this.” –Pharmacist 1 
 
“[How] I would approach it would be to talk with them a little bit about quality 
measures and specifically relating how perhaps their HEDIS measures relate a 
lot to our Star Ratings and the pharmacy. And begin the conversation that way. 
And say that obviously…we want to provide optimal patient care, but we also are 
being evaluated on our quality just as they are. And so then I would probably dive 
deeper into…examples of those specific measures and outline them on the 
graphic.” –Pharmacist 3 
1.3.6 Theme 6: Using the PDD infographic for pharmacist-prescriber collaboration may 
improve patient care and health outcomes. 
Pharmacists articulated that the process of using a PDD infographic to initiate 
collaborative conversations with a prescriber could lead to development of a collaborative 
working relationship with a prescriber, which would ultimately lead to improved team-based 
patient care and patient outcomes. Working alongside the prescriber to increase quality 
performance and close therapeutic gaps in care is fundamentally beneficial to the patient. 
 
“If we’re driving towards these metrics then it’s to the benefit of the patient and 
their overall health and their exposure to unnecessary costs hopefully. And a 
better quality of life. If their diabetes is under control, if they’re obtaining statin 
therapy when it’s appropriate and hopefully preventing them from having a 
cardiovascular event, that matters to a patient.” –Pharmacist 6 
 
“The continuity of care [is beneficial]; having the both providers working 
towards the goal of having the patient’s health as their priority and their 
outcomes. Trying to help the doctor [and] the doctor helping us. Total provider 
information is what I’m gathering is not out there in various practices.”  
–Pharmacist 5 
 
“Ultimately, the patient wins because these [PDD infographics] are designed to 
help them.” –Pharmacist 6 
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One pharmacist works in a community pharmacy and works in a physician’s office for 
one half day per week. She explicitly stated why increased communication and team-based care 
is needed from the patient’s perspective:  
“They [want to] know that their care is being tracked on multiple levels by people 
that actually talk to one another. Because when I’m in the doctor’s office a half 
day a week just seeing the patients trying to have this conversation…about the 
specialist appointment they had and they have this expectation that ‘Oh, well 
weren’t the notes from the doctor sent over to you?’ Maybe they were, maybe they 
weren’t. and half the time they’re just sitting in a pile somewhere waiting to be 
uploaded into the computer system and so I feel like from a patient 
perspective…they assume that we are talking to each other when really we’re not 
that much.” –Pharmacist 3 
 
1.4 DISCUSSION 
Pharmacist-prescriber collaboration has been shown to enhance patient care and improve 
patient outcomes.[27, 28] Collaboration in health care is defined as health care professionals 
assuming complementary roles and cooperatively working together, sharing responsibility for 
problem-solving and making decisions to formulate and carry out plans for patient care.[29] The 
Center for Disease Control and Prevention (CDC), American Public Health Association, and 
National Governors Association call for the increased utilization of pharmacists in the provision 
of direct patient care as members of integrated health care provider teams.[2, 8, 9] Collaboration is 
becoming increasingly vital as our healthcare system shifts from fee-for-service to value-based 
and providers are held accountable for patient outcomes.[2, 27, 28] 
Several studies emphasize that face-to-face meetings between pharmacists and 
prescribers are integral in establishing trust and building collaboration.[3, 11, 12] However, 
literature provides little guidance on how pharmacists can structure these face-to-face meetings 
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to develop collaborative working relationships with prescribers. The process of using a PDD 
infographic described in this study seeks to fill this gap by providing a systematic approach for 
pharmacists to initiate the collaborative process. 
Carroll and colleagues found that prescribers found the infographic valuable when its 
contents were delivered in a face-to-face discussion.[25] This study assessed community 
pharmacists’ acceptability and perceived useful of a PDD infographic in facilitating collaborative 
conversations with prescribers on mutual patients. Constructs of the Technology Acceptance 
Model and descriptions of the results that apply to each construct follows: 
Perceived Usefulness 
With the exception of Carroll and colleagues, infographics have not been studied in the 
pharmacy space; however, they have been used in other health care arenas such as public 
health.[24] Pharmacists perceived that the design of the infographic made it a useful tool to 
facilitate conversation. Pharmacists also reported it would be engaging for the end user, the 
prescriber, because data presented in an infographic format made it easy to discern a lot of 
information quickly. Not only did the infographic convey a lot of information in a clear format, 
but the process of placing prescription dispensing data into an infographic allows pharmacists to 
give context to the data. The data describes medication-related patterns and therapeutic gaps in 
care for patients that have already chosen the prescriber for their medical needs and have chosen 
that particular pharmacy to obtain their chronic medications. Armed with this information, using 
this tool, can a pharmacist and prescriber come to mutual understanding of a patient population’s 
medication-related needs? The pharmacists in this study surmised that they can. 
 
 
 17 
Perceived Usefulness for Patient 
Pharmacists recognized that the end goal of utilizing the PDD infographic to initiate 
collaborative conversations with prescribers is to ultimately benefit patients. The goal of initially 
discussing mutual patients with prescribers is to discern different ways to better work together to 
care for these patients. Part of this work includes working together to close therapeutic gaps in 
care. Pharmacists in the study felt that breaking down communication barriers using an 
infographic would help facilitate that work.  
External Variables  
The biggest external variable reported to affect use of the PDD infographic was quality 
measures. Quality measures and incentive payment programs place an external pressure on 
prescribers and pharmacists to meet goals.[30, 31] Quality measures affect patient care priorities of 
both prescribers and pharmacists, therefore quality measures must be taken into account when 
looking at how to initiate collaboration between the two providers. Pharmacists discerned that 
the reporting of quality measures that are important to the prescriber, especially those that affect 
prescriber reimbursement, would be most useful to the prescriber. Therefore, the PDD 
infographic should focus on medication-related quality measures that are of priority to the end 
user, the prescriber.  
Perceived Ease of Use 
Using prescription dispensing data to initiate collaboration with prescribers is not 
common practice. The PDD infographic process is unique in that it provides the community 
pharmacist with a process to initiate discussion with prescribers using data that is readily 
available in the community pharmacy. Prescription dispensing data is rich with information. 
Chronic disease states can be deduced based on medications filled; medication adherence, 
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polypharmacy, and a wealth of quality measures pertaining to a specific patient population can 
be assessed.[25]  
Pharmacists reported that perceived ease of use for preparing the PDD infographic to be 
fairly good, with most of the process being straightforward and do-able. The biggest concern 
expressed was about pharmacists’ capability and the time required to pull the needed data from 
community pharmacy prescription dispensing systems. It was acknowledged that data pull 
capabilities need to be universally present in all computer systems. 
Attitude Toward Using and Behavioral Intention to Use 
Pharmacists asserted a positive attitude toward using the PDD infographic to facilitate 
collaborative conversations on mutual patients with a prescriber. All participants stated they 
would like to use this process within their own pharmacies and intend to use this process in the 
future. 
1.4.1 Limitations 
Participants were taken from a convenience sample of pharmacists who are members of 
the Pennsylvania Pharmacists Care Network and attended a state pharmacy association annual 
meeting. These pharmacists are intrinsically motivated to initiate and develop collaborative 
working relationships with prescribers. A small sample (n = 10) from one state limits 
generalizability of study results. Further research is warranted to determine the acceptability of 
the PDD infographic across a range of community pharmacists.  
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1.4.2 Next Steps 
The process of using a PDD infographic to initiate collaborative conversations with 
prescribers is currently being tested in pharmacies of the Pennsylvania Pharmacists Care 
Network.  
1.5 CONCLUSION 
The PDD infographic is an innovative approach to initiate pharmacist-prescriber 
collaborative conversations. Overall, the pharmacists perceived the PDD infographic to be a 
useful tool to facilitate crucial conversations with prescribers regarding mutual patients. 
Implementing the PDD infographic as part of clinical practice may foster collaboration, team-
based care, and improved patient outcomes. 
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APPENDIX: KEY INFORMANT INTERVIEW GUIDE 
Perceived Ease of Use (PE)  
1. What is your initial impression of the infographic? 
a. How clear is the infographic to you in terms of what data it represents? 
2. How easy do you think it would be to pull the data from your dispensing system to 
populate the infographic? 
 
Perceived Usefulness (U) 
3. How could the infographic be a useful tool in initiating a collaborative discussion with a 
prescriber on the care of mutual patients? 
a. Describe how the infographic may be used to facilitate conversation with a 
prescriber. 
Behavioral intention to use system (BI)  
b. How could YOU see YOURSELF using the infographic when discussing 
collaborative patient care opportunities with a prescriber? 
Attitude Toward Using (A) 
a. What would you like about using an infographic to facilitate collaborative 
conversations with a prescriber? 
 
Perceived usefulness for self (PU-SELF)  
4. In terms of usefulness, please describe how this infographic can impact your provision of 
patient care services. 
a. How is the process of using an infographic different or the same from what 
anything you have done in the past to promote collaboration? 
b. What support or training do you think you would want in order to have a 
successful initial meeting with a prescriber? 
 
Perceived usefulness for patient (PU-PT)  
5. How do you see the process of having a discussion with a prescriber regarding mutual 
patients as being useful or beneficial to patients? 
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